Cyteir Therapeutics (CYT)
NASDAQ:CYT
US Market

Cyteir Therapeutics (CYT) Stock Forecast & Price Target

26 Followers
See the Price Targets and Ratings of:
See bloggers sentiment and opinion on CYT
>

CYT Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Cyteir
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CYT Stock 12 Months Forecast

There Are No Analyst Ratings for CYT In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CYT Financial Forecast

CYT Earnings Forecast

Next quarter’s earnings estimate for CYT is -$0.25 with a range of -$0.25 to -$0.25. The previous quarter’s EPS was -$0.35. CYT beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.62% of the time in the same period. In the last calendar year CYT has Outperformed its overall industry.
Next quarter’s earnings estimate for CYT is -$0.25 with a range of -$0.25 to -$0.25. The previous quarter’s EPS was -$0.35. CYT beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.62% of the time in the same period. In the last calendar year CYT has Outperformed its overall industry.
No data currently available

CYT Sales Forecast

Next quarter’s sales forecast for CYT is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CYT beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 44.67% of the time in the same period. In the last calendar year CYT has Underperformed its overall industry.
Next quarter’s sales forecast for CYT is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CYT beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 44.67% of the time in the same period. In the last calendar year CYT has Underperformed its overall industry.

CYT Analyst Recommendation Trends

CYT has not received any ratings in the last 3 months.
CYT has not received any ratings in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wedbush
$3.00
Buy
7.53%
Upside
Reiterated
Wedbush Sticks to Its Buy Rating for Cyteir Therapeutics (CYT)
Morgan Stanley
$2.00
Sell
-28.32%
Downside
Reiterated
Bank of America Securities
$2.00
Hold
-28.32%
Downside
Reiterated
J.P. Morgan
Hold
Downgraded
JP Morgan Downgrades Cyteir Therapeutics to Neutral

Best Analysts Covering Cyteir Therapeutics

Which Analyst Should I Follow If I Want to Buy CYT and Sell After:
1 Month
Jeffrey HungMorgan Stanley
Success Rate
2/5 ratings generated profit
40%
Average Return
-7.84%
reiterated a sell rating 5 months ago
Copying Jeffrey Hung's trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of -7.84% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Jeffrey HungMorgan Stanley
Success Rate
0/5 ratings generated profit
0%
Average Return
-23.34%
reiterated a sell rating 5 months ago
Copying Jeffrey Hung's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -23.34% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Jeffrey HungMorgan Stanley
Success Rate
0/5 ratings generated profit
0%
Average Return
-56.92%
reiterated a sell rating 5 months ago
Copying Jeffrey Hung's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -56.92% per trade.
2 Years
Jeffrey HungMorgan Stanley
Success Rate
0/5 ratings generated profit
0%
Average Return
-58.42%
reiterated a sell rating 5 months ago
Copying Jeffrey Hung's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -58.42% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CYT Stock Forecast FAQ

What is CYT’s average 12-month price target, according to analysts?
Currently, no data Available
What is CYT’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CYT, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CYT a Buy, Sell or Hold?
      Currently, no data Available
      What is Cyteir Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Cyteir Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CYT?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis